RPG Life Sciences Share Price

RPG LifeScience.

CMP as on 20-May-22 15:42

₹ 511.65
11.70 2.34%

Open

₹ 504.00

Turnover (lac)

₹ 46

Prev. Close

₹ 499.95

Day's Vol (shares)

₹ 8,905

Day's Range (₹)

₹ 504.00
₹ 515.70

CMP as on20-May-22 15:43

₹ 508.40
8.9 1.78%

Open

₹ 508.35

Turnover (lac)

₹ 14

Prev. Close

₹ 499.50

Day's Vol (shares)

₹ 284

Day's Range

₹ 504.85
₹ 513.05

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 22-Apr-2022 - -
Audited Results RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 29, 2022, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2022. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2022 and will continue to remain closed till 48 hours after the results are made public on April 29, 2022. Kindly take this information on record. Recommended equity dividend of Rs. 9.60 per share of Rs. 8/- each (120%) for the financial year ended March 31, 2022, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m. (As Per BSE Announcement Dated on 29.04.2022)
Board Meeting - 18-Jan-2022 - -
RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2022 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2021. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities by Designated Persons and their immediate relatives is closed from January 1 2022 and will continue to remain closed till 48 hours after the results are made public on January 25 2022. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Tuesday, January 25, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021, along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m. Kindly take the above on record. Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2021 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2022 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m. Kindly take the above on record. (As Per BSE Announcement dated on 25.01.2022)
Board Meeting - 18-Oct-2021 - -
Quarterly Results In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Friday, October 29, 2021, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05:20 p.m. Kindly take the above on record. (As Per BSE Announcement dated on 29.10.2021)
Board Meeting - 21-Jul-2021 - -
RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Wednesday, July 28, 2021, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2021. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from July 1, 2021 and will continue to remain closed till 48 hours after the results are made public on July 28, 2021. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Wednesday, July 28, 2021, inter alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2021 along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05:00 p.m. Kindly take the same on your record. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2021 which were approved by the Board of Directors of the Company, at its meeting held on July 28, 2021 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 03:00 p.m. and concluded at 05:00 p.m. Kindly take the above on your record. (As per BSE Announcement Dated on 28/7/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity